Battin Malcolm R, Thoresen Marianne, Robinson Elizabeth, Polin Richard A, Edwards A David, Gunn Alistair Jan
Newborn Services, National Women's Health, Auckland City Hospital, Private Bag 92 024, Auckland, New Zealand.
Pediatrics. 2009 Mar;123(3):1031-6. doi: 10.1542/peds.2008-1610.
Our goal was to evaluate whether head cooling with mild systemic hypothermia for neonatal encephalopathy is associated with greater requirement for volume or inotrope support.
We studied term infants (>/=36 weeks) with moderate-to-severe neonatal encephalopathy plus abnormal amplitude integrated electroencephalography, randomly assigned to head cooling for 72 hours starting within 6 hours of birth, with the rectal temperature maintained at 34.5 degrees C +/- 0.5 degrees C (n = 112), or conventional care (n = 118).
This was a multicenter randomized, controlled study (the CoolCap trial). The primary outcome was the time relationship between mean arterial blood pressure and subsequent administration of inotropes or volume administration.
Pooled data from 0 to 76 hours after randomization revealed no difference in mean arterial blood pressure between groups and significantly lower mean heart rate during cooling. The use of inotropes or volume was related to preceding mean arterial blood pressure and not to treatment group in the first 24 hours. In contrast, from 24 to 76 hours, there was no effect of mean arterial blood pressure, but there was an overall reduction in pressure support over time and significantly more frequent pressure support in the cooled group than in controls.
Mild systemic hypothermia did not affect arterial blood pressure or initial treatment with inotropes or volume in infants with moderate-to-severe encephalopathy but was associated with an apparent change in physician behavior, with slower withdrawal of therapy in cooled infants.
我们的目标是评估对新生儿脑病采用轻度全身低温头部降温是否会导致对容量或血管活性药物支持的需求增加。
我们研究了足月(≥36周)患有中重度新生儿脑病且振幅整合脑电图异常的婴儿,将其随机分为两组,一组在出生后6小时内开始进行72小时的头部降温,直肠温度维持在34.5℃±0.5℃(n = 112),另一组接受常规护理(n = 118)。
这是一项多中心随机对照研究(CoolCap试验)。主要结局是平均动脉血压与随后使用血管活性药物或进行容量治疗之间的时间关系。
随机分组后0至76小时的汇总数据显示,两组之间平均动脉血压无差异,且降温期间平均心率显著较低。在最初24小时内,血管活性药物或容量的使用与先前的平均动脉血压有关,而与治疗组无关。相比之下,在24至76小时内,平均动脉血压没有影响,但随着时间推移压力支持总体减少,且降温组的压力支持比对照组更频繁。
轻度全身低温对中重度脑病婴儿的动脉血压或血管活性药物或容量的初始治疗没有影响,但与医生行为的明显变化有关,即降温婴儿的治疗撤药较慢。